57 Results for "

Cachexia

" in MedChemExpress (MCE) Product Catalog:
Products (57)

57 Results for "Cachexia" in MCE Product Catalog:

46
46 Publications Verification
Referencia número: HY-N0109
No. CAS: 10338-51-9
Synonyms: Rhodioloside
Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
loading...
    loading...
46
46 Publications Verification
Referencia número: HY-N0109R
No. CAS: 10338-51-9
Synonyms: Rhodioloside (Standard)
Salidroside (Standard) is the analytical standard of Salidroside. This product is intended for research and analytical applications. Salidroside (Rhodioloside) is a prolyl endopeptidase inhibitor. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activating mTOR signalling. Salidroside protects dopaminergic neurons by enhancing PINK1/Parkin-mediated mitophagy.
loading...
    loading...
36
36 Cited Publications
Referencia número: HY-112288
No. CAS: 432001-19-9
Pureza:  99.90%
Synonyms: TTI-101
C188-9 (TTI-101) is a STAT3 inhibitor with a Kd value of 4.7 nM. C188-9 targets the SH2 domain of STAT3, blocks the processes of STAT3 ligand binding, receptor recruitment, homodimerization and phosphorylation, and regulates STAT3-mediated genes associated with tumorigenesis and radioresistance. C188-9 regulates STAT1-mediated genes related to radioresistance and reduces the activation level of STAT1. C188-9 downregulates the expression of DNMT1, enhances DAC-induced demethylation and re-expression of RASSF1A, and simultaneously potentiates the anti-tumor effect of DAC on pancreatic cancer cells. C188-9 inhibits both anchorage-dependent and anchorage-independent growth of cancer cells, induces Apoptosis, blocks the growth of tumor xenografts, and suppresses muscle atrophy. C188-9 maintains muscle mass, increases body weight and improves grip strength in tumor-bearing mice. C188-9 can be used in research related to head and neck squamous cell carcinoma, pancreatic cancer, sepsis-related skeletal muscle wasting, non-small cell lung cancer, acute myeloid leukemia and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Referencia número: HY-14734
No. CAS: 249921-19-5
Pureza:  99.94%
Synonyms: RC-1291; ONO-7643
Target:  

GHSR

Áreas de investigación:  

Endocrinology Cancer

Anamorelin (RC-1291) is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Referencia número: HY-12176
No. CAS: 173334-57-1
Pureza:  98.78%
Synonyms: CGP 60536; CGP60536B; SPP 100
Target:  

Renin Autophagy

Áreas de investigación:  

Cardiovascular Disease Cancer

Aliskiren is an orally active, highly potent and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren can be used for the research of hypertension, cardiovascular diseases and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Referencia número: HY-12177
No. CAS: 173334-58-2
Pureza:  99.62%
Synonyms: CGP 60536 hemifumarate; CGP60536B hemifumarate; SPP 100 hemifumarate
Target:  

Renin Autophagy

Áreas de investigación:  

Cardiovascular Disease Cancer

Aliskiren (CGP 60536; CGP60536B; SPP 100) hemifumarate is an orally active and selective renin inhibitor, with IC50 of 1.5 nM. Aliskiren hemifumarate can be used for the research of hypertension, cardiovascular diseases and cancer cachexia .
loading...
    loading...
11
11 Cited Publications
Referencia número: HY-14734A
No. CAS: 861998-00-7
Pureza:  99.59%
Synonyms: RC-1291 hydrochloride; ONO-7643 hydrochloride
Target:  

GHSR

Áreas de investigación:  

Endocrinology Cancer

Anamorelin (RC-1291) hydrochloride is an orally active Ghrelin receptor agonist with an EC50 of 0.74 nM. Anamorelin hydrochloride can promote appetite, increase body weight, and stimulate the secretion of growth hormone and insulin-like growth factor-1. Anamorelin hydrochloride can be used in the research of anorexia and cancer cachexia .
loading...
    loading...
5
5 Cited Publications
Referencia número: HY-100186
No. CAS: 1539314-06-1
Pureza:  99.74%
GSK-2881078 is an orally active and nonsteroidal selective androgen receptor modulator (SARM) which act as partial AR agonists in androgenic tissues while mainly as complete AR agonists in synthetic metabolic tissues,induces AR-mediated transcriptional activation in PC3(AR)2 cells (EC50 = 3.99 nM) and the effect can be inhibited by the non-steroidal AR antagonist Bicalutamide. GSK-2881078 can be used in research of muscle weakness and cachexia associated with both chronic and acute illness .
loading...
    loading...
3
3 Cited Publications
Referencia número: HY-P99241
No. CAS: 2368950-15-4
Synonyms: PF 06946860

Áreas de investigación:  

Cancer

Ponsegromab is a Growth differentiation factor 15 (GDF15) inhibitor with human, cynomolgus monkey, and mouse target IC50 values of 0.123 nM, 0.053 nM, and 0.102 nM, respectively . Ponsegromab acts as a chemosensitizer, increases intracellular reactive oxygen species, reduces glutathione levels . Ponsegromab can be used for the research of oxaliplatin-resistant colorectal cancer .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-13676
No. CAS: 595-33-5
Pureza:  99.69%
Áreas de investigación:  

Endocrinology Cancer

Megestrol acetate is a synthetic and orally active progesteronal agent. Megestrol acetate is effective as an appetite stimulant for wasting syndromes such as cachexia. Megestrol acetate decreases nuclear and cytosol androgen receptors human BPH tissue. Megestrol acetate has the potential for HIV study and downregulates autophagic catabolic pathway .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-19884B
No. CAS: 2863659-22-5
Synonyms: RM-131 TFA; BIM-28131 TFA
Target:  

GHSR

Áreas de investigación:  

Metabolic Disease

Relamorelin (RM-131) TFA, a pentapeptide ghrelin analog, is a selective ghrelin/growth hormone secretagogue receptor (GHSR) agonist with a Ki of 0.42 nM for GHS-1a receptor. Relamorelin TFA is centrally penetrant. Relamorelin TFA increases growth hormone levels and accelerates gastric emptying. Relamorelin TFA has the potential for cachexia, gastroparesis, and gastric/intestinal dysmobility disorders research .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-B0580B
No. CAS: 66635-93-6
Synonyms: (+)-Ketorolac
Target:  

Ras

Áreas de investigación:  

Cancer

(R)-Ketorolac is an orally active Cdc42 and Rac1 inhibitor. (R)-Ketorolac inhibits GTPase. (R)-Ketorolac alters ovarian cancer cell behaviors critical for invasion and metastasis. (R)-Ketorolac ameliorates cancer-associated cachexia .
loading...
    loading...
2
2 Cited Publications
Referencia número: HY-13676R
No. CAS: 595-33-5
Áreas de investigación:  

Endocrinology Cancer

Megestrol acetate (Standard) is the analytical standard of Megestrol acetate. This product is intended for research and analytical applications. Megestrol acetate is a synthetic and orally active progesteronal agent. Megestrol acetate is effective as an appetite stimulant for wasting syndromes such as cachexia. Megestrol acetate decreases nuclear and cytosol androgen receptors human BPH tissue. Megestrol acetate has the potential for HIV study and downregulates autophagic catabolic pathway .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-148349
No. CAS: 2755890-53-8
Pureza:  98.44%
Target:  

Melanocortin Receptor

Áreas de investigación:  

Neurological Disease Metabolic Disease

PF-07258669 is an orally active melanocortin-4 receptor (MC4R) antagonist that antagonizes MC4R with an IC50 of 13 nM (Ki=0.46 nM). PF-07258669 can be used for the research of cachexia, anorexia, or anorexia nervosa .
loading...
    loading...
1
1 Cited Publications
Referencia número: HY-129692
No. CAS: 27570-38-3
Pureza:  93.06%
Target:  

iGluR

Withanone is an active ingredient from the roots of Withania somnifera and a GRP75 inhibitor. Withanone has multifunctional neuroprotective effects in alleviating cognitive dysfunction. In neuron-like cells, Withanone can inhibit NMDA-induced excitotoxicity. Withanone can inhibit white adipose tissue browning by blocking the formation of the GRP75-ANT2-UCP1 complex, thereby alleviating cancer-related cachexia. Withanone can be used in the research of tumors and nervous system diseases .
loading...
    loading...
Referencia número: HY-P5971
No. CAS: 1456699-27-6
Synonyms: Mifomelatide
Target:  

Melanocortin Receptor

Áreas de investigación:  

Neurological Disease Metabolic Disease

TCMCB07, a cyclic nonapeptide peptide, is an orally active and brain-penetrant melanocortin receptor 4 (MC4R) antagonist. TCMCB07 plays an important role in cachexia. TCMCB07 has potential transport capabilities .
loading...
    loading...
Referencia número: HY-14820A
No. CAS: 945212-59-9
Pureza:  98.96%
Synonyms: EP-1572 acetate; AEZS-130 acetate
Target:  

GHSR

Áreas de investigación:  

Neurological Disease Endocrinology Cancer

Macimorelin (EP-1572) acetate, a GH secretagogue, is an orally active GHSR agonist. Macimorelin acetate stimulates GH release. Macimorelin acetate can be used in the research of adult growth hormone deficiency (AGHD), and Cancer anorexia-cachexia syndrome (CACS) .
loading...
    loading...
Referencia número: HY-129531
No. CAS: 445222-91-3
Pureza:  98.16%
Target:  

E1/E2/E3 Enzyme

Áreas de investigación:  

Neurological Disease

MuRF1-IN-1 is an orally active MuRF1 inhibitor. MuRF1-IN-1 can inhibit the interaction between MuRF1 and titin as well as E3 ligase activity. MuRF1-IN-1 can alleviate skeletal muscle atrophy and dysfunction in cardiac cachexia .
loading...
    loading...
Referencia número: HY-164027
No. CAS: 2614161-13-4
Target:  

E1/E2/E3 Enzyme

Áreas de investigación:  

Metabolic Disease Cancer

MyoMed 205 is an orally active muscle ring finger protein 1 (MuRF1) inhibitor. MyoMed-205 reduces ubiquitination and subsequent proteasomal degradation of muscle proteins by inhibiting MuRF1 activity. MyoMed 205 augments muscle performance, attenuates muscle weight loss and alleviates disease-induced weight loss. MyoMed 205 can be used for the research of cancer cachexia, type 2 diabetes mellitus, and heart failure with preserved ejection fraction .
loading...
    loading...
Referencia número: HY-B1834
No. CAS: 3562-63-8
Megestrol is an orally active glucocorticoid and progesterone receptor agonist. Megestrol can alleviate anorexia, cachexia or unexplained significant weight loss associated with acquired immunodeficiency syndrome (AIDS). Megestrol may cause manifestations similar to those of glucocorticoids and increase the risk of mental disorders .
loading...
    loading...